Anti-TNF-α in the treatment of non-infectious uveitis

被引:3
作者
Hoogewoud, Florence [1 ,2 ]
Kowalczuk, Laura [2 ,3 ]
Bousquet, Elodie [1 ,3 ]
Brezin, Antoine [1 ,3 ]
Touchard, Elodie [4 ]
Buggage, Ronald [4 ]
Bordet, Thierry [4 ]
Behar-Cohen, Francine [1 ,3 ]
机构
[1] Univ Paris, Ophtalmopole Hop Cochin, Assistance Publ Fopitaux Paris, 27 Rue Faubourg St Jacques, F-75014 Paris, France
[2] Univ Lausanne, Dept Ophtalmol, Hop Ophtalmol Jules Gonin, Lausanne, Switzerland
[3] Univ Paris, Inserm UMR 1138, Physiopathol Malad Oculaires Innovat Therapeut, Ctr Rech Cordeliers, 15 Rue Ecole Med, F-75006 Paris, France
[4] Eyevensys SAS, Paris, France
来源
M S-MEDECINE SCIENCES | 2020年 / 36卷 / 10期
关键词
TUMOR-NECROSIS-FACTOR; LONG-TERM EFFICACY; ANTERIOR UVEITIS; ELECTROTRANSFER; ADALIMUMAB; INFLIXIMAB; DELIVERY; PRINCIPLES; THERAPY; FLARES;
D O I
10.1051/medsci/2020160
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-infectious uveitis is a heterogenous group of potentially blinding ocular autoimmune diseases that may represent a manifestation of a systemic condition or may affect the eyes only. A systemically administered anti-TNF has recently been approved for the treatment of non-infectious uveitis, broadening the therapeutic arsenal available to control intraocular inflammation and reduce uveitis complications that can lead to vision loss. When uveitis affects only the eyes, a local anti-TNF-alpha administration strategy could optimize the ocular therapeutic effect and reduce undesirable systemic side-effects. A new ocular method of non-viral gene therapy, currently in development, may broaden the indications for ocular anti-TNF-alpha agents, not only for uveitis but also for other diseases in which TNF-alpha-mediated neuro-inflammation has been demonstrated.
引用
收藏
页码:893 / 899
页数:7
相关论文
共 54 条
[1]   Anti-tumor necrosis factor agents in sarcoidosis: A systematic review of efficacy and safety [J].
Adler, Brandon L. ;
Wang, Catherine J. ;
Thanh-Lan Bui ;
Schilperoort, Hannah M. ;
Armstrong, April W. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 48 (06) :1093-1104
[2]   DNA electrotransfer:: its principles and an updated review of its therapeutic applications [J].
André, F ;
Mir, LM .
GENE THERAPY, 2004, 11 (Suppl 1) :S33-S42
[3]  
[Anonymous], 2018, Lancet Oncol, V19, pe581
[4]   Multiplex Cytokine Analysis of Aqueous Humor in Juvenile Idiopathic Arthritis-Associated Anterior Uveitis With or Without Secondary Glaucoma [J].
Bauer, Dirk ;
Kasper, Maren ;
Walscheid, Karoline ;
Koch, Joerg M. ;
Muether, Philipp S. ;
Kirchhof, Bernd ;
Heiligenhaus, Arnd ;
Heinz, Carsten .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[5]   Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases [J].
Billmeier, Ulrike ;
Dieterich, Walburga ;
Neurath, Markus F. ;
Atreya, Raja .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (42) :9300-9313
[6]   Non-viral ocular gene therapy: Potential ocular therapeutic avenues [J].
Bloquel, C. ;
Bourges, J. L. ;
Touchard, E. ;
Berdugo, M. ;
BenEzra, D. ;
Behar-Cohen, F. .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (11) :1224-1242
[7]   Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases [J].
Bonacini, Martina ;
Soriano, Alessandra ;
Cimino, Luca ;
De Simone, Luca ;
Bolletta, Elena ;
Gozzi, Fabrizio ;
Muratore, Francesco ;
Nicastro, Maria ;
Belloni, Lucia ;
Zerbini, Alessandro ;
Fontana, Luigi ;
Salvarani, Carlo ;
Croci, Stefanie .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[8]   Immune Response and Intraocular Inflammation in Patients With Leber Hereditary Optic Neuropathy Treated With Intravitreal Injection of Recombinant Adeno-Associated Virus 2 Carrying the ND4 Gene A Secondary Analysis of a Phase 1/2 Clinical Trial [J].
Bouquet, Celine ;
Clermont, Catherine Vignal ;
Galy, Anne ;
Fitoussi, Serge ;
Blouin, Laure ;
Munk, Marion R. ;
Valero, Sonia ;
Meunier, Sandrine ;
Katz, Barrett ;
Sahel, Jose Alain ;
Thomasson, Nitza .
JAMA OPHTHALMOLOGY, 2019, 137 (04) :399-406
[9]   Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept [J].
Braun, J ;
Baraliakos, X ;
Listing, J ;
Sieper, J .
ARTHRITIS AND RHEUMATISM, 2005, 52 (08) :2447-2451
[10]  
Brezin AP, 2010, SEMIOLOGIE CLASSIFIC